Literature DB >> 1401612

Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study.

D B Simons1, R S Schwartz, W D Edwards, P F Sheedy, J F Breen, J A Rumberger.   

Abstract

OBJECTIVES: The aim of this study was to determine the relation between coronary artery calcification detected by ultrafast computed tomographic scanning and histopathologic coronary artery disease.
BACKGROUND: Recent studies suggest that discrete coronary artery calcification as visualized by ultrafast computed tomographic scanning may facilitate the noninvasive detection or estimation, or both, of the in situ extent of coronary disease. Such quantitative relations have not been established.
METHODS: Thirteen consecutive perfusion-fixed autopsy hearts (from eight male and five female patients aged 17 to 83 years) were scanned by ultrafast computed tomographic scanning in contiguous 3-mm tomographic sections. The major epicardial arteries were dissected free, positioned longitudinally and scanned again in cross section. Coronary artery calcification in a coronary segment was defined as the presence of one or more voxels with a computed tomographic density > 130 Hounsfield units. Each epicardial artery was sectioned longitudinally, stained and measured with a planimeter for quantification of cross-sectional and atherosclerotic plaque areas at 3-mm intervals, corresponding to the computed tomographic scans. A total of 522 paired coronary computed tomographic and histologic sections were studied.
RESULTS: Direct relations were found between ultrafast computed tomographic scanning coronary artery calcium burden and atherosclerotic plaque area and percent lumen area stenosis. However, the range for plaque area or percent lumen stenosis, or both, associated with a given calcium burden was broad. Three hundred thirty-one coronary segments showed no calcification by computed tomography. Although atherosclerotic disease was found in several corresponding pathologic specimens, > 97% of these noncalcified segments were associated with nonobstructive disease (< 75% area stenosis); if no calcification was determined in an entire coronary vessel, all corresponding coronary disease was found to be nonobstructive. To determine the relation between arterial calcification and any atheromatous disease, computed tomographic calcium burden for each segment was paired with the histologic absence or presence of disease. Ultrafast computed tomographic scanning had a sensitivity and specificity of 59% and 90% and a negative and positive predictive value of 65% and 87%, respectively. A direct correlation was found (r = 0.99) between total calcium burden calculated from tomographic scans of the heart as a whole and scans of the arteries obtained in cross section.
CONCLUSIONS: The detection of coronary calcification by ultrafast computed tomographic scanning is highly predictive of the presence of histopathologic coronary disease, but the use of this technique to define the extent of coronary disease may be limited. However, the absence of coronary calcification at any site is highly specific for the absence of obstructive disease.

Entities:  

Mesh:

Year:  1992        PMID: 1401612     DOI: 10.1016/0735-1097(92)90367-v

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  60 in total

Review 1.  Vascular and valvar calcification: recent advances.

Authors:  A Farzaneh-Far; D Proudfoot; C Shanahan; P L Weissberg
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

2.  Spectrum bias: patient selection may affect performance of calcium volume in detecting carotid stenosis.

Authors:  Basar Sarikaya; Alexander M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-08       Impact factor: 3.825

3.  Absence of left ventricular concentric hypertrophy: a prerequisite for zero coronary calcium score.

Authors:  Shoichi Ehara; Nobuyuki Shirai; Takuhiro Okuyama; Kenji Matsumoto; Yoshiki Matsumura; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2010-12-23       Impact factor: 2.037

4.  Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Lu Wang; Michael Jerosch-Herold; David R Jacobs; Eyal Shahar; Robert Detrano; Aaron R Folsom
Journal:  J Am Coll Cardiol       Date:  2006-08-17       Impact factor: 24.094

5.  The influence of coronary calcium score on the interpretation of myocardial perfusion imaging.

Authors:  Mohamed Mouden; Jan Paul Ottervanger; Jorik R Timmer; Stoffer Reiffers; Ad H J Oostdijk; Siert Knollema; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2013-12-07       Impact factor: 5.952

6.  Correlation between carotid bifurcation calcium burden on non-enhanced CT and percentage stenosis, as confirmed by digital subtraction angiography.

Authors:  B Sarikaya; B Lohman; A M McKinney; S Gadani; M Irfan; L Lucato
Journal:  Br J Radiol       Date:  2011-09-06       Impact factor: 3.039

7.  TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.

Authors:  K E Watson; K Boström; R Ravindranath; T Lam; B Norton; L L Demer
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 8.  What is the role of calcium scoring in the age of coronary computed tomographic angiography?

Authors:  Parag H Joshi; Michael J Blaha; Roger S Blumenthal; Ron Blankstein; Khurram Nasir
Journal:  J Nucl Cardiol       Date:  2012-12       Impact factor: 5.952

Review 9.  Coronary computed tomographic angiography (CCTA) in community hospitals: "current and emerging role".

Authors:  Rakesh K Sharma; Donald J Voelker; Rajiv K Sharma; Vibhuti N Singh; Girish Bhatt; Mathilde Moazazi; Teresa Nash; Hanumanth K Reddy
Journal:  Vasc Health Risk Manag       Date:  2010-05-25

Review 10.  Cardiac risk stratification: role of the coronary calcium score.

Authors:  Rakesh K Sharma; Rajiv K Sharma; Donald J Voelker; Vibhuti N Singh; Deepak Pahuja; Teresa Nash; Hanumanth K Reddy
Journal:  Vasc Health Risk Manag       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.